HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels

• Main Authors: Maria Rendina (Author), Ernesto Paoletti (Author), Nunzia Labarile (Author), Antonella Marra (Author), Andrea Iannone (Author), Antonino Castellaneta (Author), Elisabetta Bussalino (Author), Maura Ravera (Author), Antonio Schena (Author), Nicola M. Castellaneta (Author), Michele Barone (Author), Simona Simone (Author), Loreto Gesualdo (Author), Alfredo Di Leo (Author)
• Format: Book
• Published: SAGE Publishing, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/aim: Direct-acting antivirals (DAAs) have improved the treatment of HCV-positive kidney transplant recipients (KTRs). However, their medium-term follow-up effects on graft function are conflicting. This study aimed to analyze how the interplay between DAAs, calcineurin inhibitors (CNI), a...